Comparison of spirometric z-scores with FEV1 percent prediction in predicting exacerbations in elderly COPD patients Source: International Congress 2016 – In-patient and out-patient COPD management Year: 2016
FEV1 /Height2 could be a better alternative than FEV1 in predicting all cause mortality in patients with COPD Source: Annual Congress 2008 - COPD - clinical and epidemiological aspects Year: 2008
Changes in spirometry (FVC and FEV1 ) in a closed population of COPD patients using new standarized values for Mexican people Source: Eur Respir J 2003; 22: Suppl. 45, 69s Year: 2003
Improved survival with increased IC/TLC ratio, DLCO and FEV1 in an analysis of a COPD pulmonary function database Source: Annual Congress 2011 - Lung and airway function Year: 2011
Prediction of all cause mortality in a population sample is improved by using FEV1 quotient Source: Annual Congress 2005 - Assessing the relevance of obstructive airway diseases Year: 2005
The evaluation of different factors that cause FEV1 decline in patients with COPD Source: Eur Respir J 2001; 18: Suppl. 33, 135s Year: 2001
The value of FENO50 measurement in COPD – results from the TIE-study Source: International Congress 2017 – Current challenges in COPD evaluation Year: 2017
FEV1 decline in occupational asthma Source: Eur Respir J 2003; 22: Suppl. 45, 488s Year: 2003
Biomarkers to predict FEV1 decline in smokers and early-onset COPD. Source: Virtual Congress 2020 – Intercellular communication in tissue remodelling of chronic lung diseases Year: 2020
Spirometric changes in bronchodilation tests as predictors of asthma diagnosis and treatment response in patients with FEV1 =80% predicted Source: Virtual Congress 2021 – Advances in asthma treatment Year: 2021
Lung function testing in the elderly – can we still use FEV1/FVC < 70% as a criterion of COPD? Source: Eur Respir J 2006; 28: Suppl. 50, 613s Year: 2006
FEV6 and FEV1/FEV6 have higher association with small airway function and oxygen saturation than FVC and FEV1/FVC in patients with asthma. Source: Virtual Congress 2020 – Lung function tests and exhaled biomarkers Year: 2020
FVC decline over 1 year predicts mortality but not subsequent FVC decline in patients with IPF Source: International Congress 2017 – Idiopathic pulmonary fibrosis: from the bench to the bedside Year: 2017
Has the determination of the rate of decline of FEV1 added value in addition to the determination of FEV1/FVC and FEV1 Source: International Congress 2016 – Man versus machine: waves, frequency, and more in lung function Year: 2016
Accuracy for DLco impairment through ventilatory efficiency indices in smokers without COPD. Source: Virtual Congress 2021 – Lung function evaluation and assessment of airway diseases Year: 2021
FEV6 or FVC to detect airway obstruction in the community setting? Source: Annual Congress 2007 - PG17 - Lung function measurement in the community Year: 2007
Comparative study of FEV1 /FVC and FEV1 /FEV6 to screen COPD patients Source: Eur Respir J 2005; 26: Suppl. 49, 511s Year: 2005
The predictive value of baseline spirometry values and reversibility history of the patient for a significant reversibility response in children Source: Eur Respir J 2002; 20: Suppl. 38, 539s Year: 2002
Re-assessing the importance of FEV1 decline Source: Eur Respir Monogr 2015; 69: 134-142 Year: 2015
Lung function decline, chronic bronchitis and occupational exposures during the follow-up of the ECRHS Source: Annual Congress 2005 - Better understanding of lung function decline and COPD Year: 2005